Hypodermic Needles in Hard Plastic Unit Packaging

Optimized processability

Each needle is sterile-packed individually in a hard plastic packaging (cutting a blister pack is not required).

Compact unit pack design takes up little space in secondary packaging when being by-packed.

Packaging design (rips, flanges, round shape) supports compatibility with feeders and automated pick-and-place systems.

Color-coded labels and barcode on label enable in-line product identification by a vision system.

Smooth administrations

Ergonomic design of the packaging allows a firm grip resulting in a very easy opening and removal of the cap.

Proprietary grinding process results in an exceptionally sharp lancet point able to penetrate tissue smoothly.

Homogeneously-siliconized cannula supports excellent gliding performance during administrations.

Tamper-proof labels on unit pack confirms unused state of needle.

Secure connection to syringes

Needlehub complies to ISO 80369-7, allowing a proper connection to syringes.

Go to article: Home | Waive goodbye to vaccine patentsGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: DatwylerGo to article: Datwyler Company InsightGo to article: LabcorpGo to article: Biesterfeld Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Dr. Paul LohmannGo to article: ButterworthGo to article: SkyepharmaGo to article: BaxterGo to article: CommentGo to article: Speeding up patient access to innovative drugsGo to article: The competitive landscape of neoantigen-targeting therapeutics in oncologyGo to article: Bacterial “cell factories”: an eco-friendly approach to chemical productionGo to article: MDR set to transform how MedTech firms approach content managementGo to article: PerkinElmerGo to article: NiproGo to article: NiproGo to article: In DepthGo to article: Should UK children be vaccinated against chickenpox?Go to article: Fighting India’s ‘black fungus’ epidemicGo to article: What could a vaccine patent waiver mean for pharma manufacturing? Go to article: Algae proteins: a vision of the futureGo to article: A brief history of ALS awareness and its sparse treatments Go to article: Ferring draws closer to a microbiome breakthroughGo to article: The Solubility companyGo to article: Myonex Go to article: Owen MumfordGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue